BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 175643)

  • 1. [Complement-dependent immune cytolysis of cells from transplantable myeloid tumor].
    Iakimov M
    Acta Microbiol Virol Immunol (Sofiia); 1975; 2():52-6. PubMed ID: 175643
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Spontaneous" neoplastic transformation in vitro: influence of endogenous murine leukemia virus and serum fractions.
    Sanford KK; Handleman SL; Hartley JW; Jackson JL; Gantt RR
    J Natl Cancer Inst; 1972 Oct; 49(4):1177-89. PubMed ID: 4343474
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems with and approaches to specificity in the serologic measurement of histocompatibility and tumor-associated antigens on tumor cell surfaces.
    Klein PA
    Transplant Proc; 1980 Mar; 12(1):16-21. PubMed ID: 6154353
    [No Abstract]   [Full Text] [Related]  

  • 6. Xenogenization.
    Klein G
    Jpn J Cancer Res; 1995 May; 86(5):inside front cover. PubMed ID: 7790312
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cortisone on oncogenesis by murine sarcoma virus (Moloney).
    Shachat DA; Fefer A; Moloney JB
    Cancer Res; 1968 Mar; 28(3):517-20. PubMed ID: 4867925
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement fixation in conventional and regressing virus-induced murine leukemia.
    Rich MA; Karl S; Clymer R
    J Immunol; 1971 Jun; 106(6):1488-92. PubMed ID: 4326129
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological studies of tumor antigens in chemical- and virus-induced thymic lymphomas.
    Doell RG; Mathieson BJ
    Cancer Res; 1971 Sep; 31(9):1285-9. PubMed ID: 4329884
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the FMR antigen.
    Lilly F; Nathenson SG
    Transplant Proc; 1969 Mar; 1(1):85-9. PubMed ID: 4332534
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population.
    Proctor ML; Herscowitz HB
    J Immunol; 1975 Dec; 115(6):1642-9. PubMed ID: 1184969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some immunologically based reactions that can cause the regression of large tumor masses.
    Alexander P
    Natl Cancer Inst Monogr; 1976 Nov; 44():105-8. PubMed ID: 799755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S; Chen CH; Sabbadini E; Sehon AH
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor antigens. 3. Immunological studies of tissue and tumor antigens and serum protein production by transplantable murine tumors.
    Phillips ME
    Int Arch Allergy Appl Immunol; 1970; 38(3):282-90. PubMed ID: 4984527
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data on the cytotoxicity of anti-tumour sera.
    Elek G; Vekerdi L
    Acta Microbiol Acad Sci Hung; 1966-1967; 13(4):267-76. PubMed ID: 4963381
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunology of virus-induced tumours.
    Sjögren HO
    Mod Trends Med Virol; 1967; 1(0):207-22. PubMed ID: 4366129
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.